The regulatory closure follows a notification issued on January 29, 2026, which flagged the company for falling below the $1.00 threshold for 30 consecutive business days. Nasdaq officials monitored the stock's performance through early July, confirming that the shares maintained a closing price at or above the required minimum for 10 consecutive business days between June 25 and July 9. With this stabilization, Pomdoctor continues its operations on the exchange under the ticker symbol POM. The company remains focused on its core business of integrating AI-enabled tools and predictive analytics into its existing healthcare platform.